Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

VIBRAMYCIN

DOXYCYCLINE HYCLATE

Standard Dose
EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview VIBRAMYCIN is listed in Drugs@FDA under application 050007 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 2025-08-08 00:00:00.

Structured Monograph

Clinical summary

Approval overview VIBRAMYCIN is listed in Drugs@FDA under application 050007 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient DOXYCYCLINE HYCLATE Form and strength CAPSULE;ORAL - EQ 50MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor PFIZER Submission history Latest submission status date: 2025-08-08 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.
VIBRAMYCIN (DOXYCYCLINE HYCLATE) | Drug Monograph | MedicHelpline